Status:
COMPLETED
Patient Preference With Visicol Tablet Preparation for Colonoscopy
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
InKine Pharmaceutical
Conditions:
Preparation for Colonoscopy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine patient preference and acceptance of tablet sodium phosphate bowel preparation in patients who had polyethylene glycol (PEG) solution for their prior colonosc...
Eligibility Criteria
Inclusion
- Prior colonoscopy with PEG solution in the past one year
- Must be able to swallow tablets
Exclusion
- Patients below 18 years and above 100 years.
- Congestive heart failure
- Chronic renal failure
- Pre-existing electrolyte disorder
- Pre-existing mega-colon or a motility disorder.
- Patients with pre-existing seizure disorder.
- Patients scheduled for colonoscopy after 1:00 p.m. will be excluded from the study.
- Pregnant or lactating women
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2006
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00318305
Start Date
March 1 2005
End Date
April 1 2006
Last Update
December 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Scottsdale, Arizona, United States, 85259